Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by itntdf

T.ONC

RE:RE:RE:RE:RE:RE:RE:Andrew's Options

and it appears he holds just under half a million shares: # or Value...

November 19, 2023

T.ONC

posted this on nov. 4, now we know what was fishy

this was taken from oncy's press release: "Oncolytics expects to...

November 9, 2023

T.ONC

RE:itntdf

That would seem to be a case of 1 + 1 equals 0 and That doesn’t seem to...

November 4, 2023

T.ONC

RE:RE:The call & mid afternoon update

this was taken from oncy's press release: "Oncolytics expects to...

November 4, 2023

T.ONC

RE:The Call

No real timeframe on a partnership is one reason for such a lackluster...

November 3, 2023

T.ONC

The Call

Overall, that was unsatisfying in many respects.  Namely the comments...

November 3, 2023

T.ONC

RE:Lets try & stay on topic, this is a great and detailed repor

but will we live long enough? our model assumes that pelareorep will advance...

October 20, 2023

T.ONC

RE:New Press Release - Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023

and this is the challenge when pela is used as a rescue or third-line type of...

October 16, 2023

T.ONC

RE:RE:RE:RE:RE:Might JNJ bad news be good news for ONCY re: JNJ interest?

grab you box of crayons, go back down to your room in your mother's...

September 8, 2023

T.ONC

RE:RE:Might JNJ bad news be good news for ONCY re: JNJ interest?

must have missed where you thought i was stretching the first time. sorry...

September 8, 2023

T.ONC

Might JNJ bad news be good news for ONCY re: JNJ interest?

Johnson & Johnson JNJ announced that it is stopping a phase III study...

September 8, 2023

T.ONC

J&J sitting on cash, wanting acquisitions

While not an exact "fit" with Oncy, maybe a look at M&A...

September 4, 2023

T.ONC

RE:RE:RE:exel panc phase 3 study stopped and unblinded early

believe notable addressed part of your questions.  my point in posting...

August 24, 2023

T.ONC

biden admin to target mrna cancer treatment

In its bid to fight cancer, the Biden administration this week announced...

August 24, 2023

T.ONC

RE:exel panc phase 3 study stopped and unblinded early

"As there is no standard of care for patients with advanced pancreatic...

August 24, 2023

T.ONC

exel panc phase 3 study stopped and unblinded early

ALAMEDA, Calif., August 24, 2023--(BUSINESS WIRE)--Exelixis, Inc. ...

August 24, 2023

T.ONC

RE:RE:Canaccord Fireside Chat & pelareorep's approval in mBC

just got up to around the 14 minute mark on the webcast which i would...

August 13, 2023

T.ONC

RE:RE:RE:General comments, leading to Monday am N.R. Etc

at the risk of beating a dead horse, the 90 day mention was to finalize an...

August 12, 2023

T.ONC

RE:Upcoming well needed updates …

money talks, connerie walks. personally, i would like to see the money and...

August 7, 2023

T.ONC

RE:RE:New Press Release - Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 43rd Annual Growth Conference

suppose it is possible they could say the agreement with pancan is being...

August 4, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next

Featured Company

Interactive Capital Partners Corporation

Interactive Capital Partners Corporation V.HFM